IVVD

$0.00

(

+0.00%

)
Quote details

stock

Invivyd Inc.

NASDAQ | IVVD

2.48

USD

+$0.00

(

+0.00%

)

At Close (As of Dec 9, 2025)

$554.83M

Market Cap

-

P/E Ratio

-0.45

EPS

$3.07

52 Week High

$0.35

52 Week Low

HEALTHCARE

Sector

IVVD Chart

Recent Chart
Price Action

IVVD Technicals

Tags:

IVVD Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $24M
Total Revenue $25M
Cost Of Revenue $1.6M
Costof Goods And Services Sold $1.6M
Operating Income -$177M
Selling General And Administrative $63M
Research And Development $137M
Operating Expenses $201M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $3.1M
Income Before Tax -$170M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$170M
Comprehensive Income Net Of Tax -
Ebit -$177M
Ebitda -$174M
Net Income -$170M

Revenue & Profitability

IVVD Financials

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $24M
Total Revenue $25M
Cost Of Revenue $1.6M
Costof Goods And Services Sold $1.6M
Operating Income -$177M
Selling General And Administrative $63M
Research And Development $137M
Operating Expenses $201M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $3.1M
Income Before Tax -$170M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$170M
Comprehensive Income Net Of Tax -
Ebit -$177M
Ebitda -$174M
Net Income -$170M

IVVD Profile

Invivyd Inc. Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Invivyd Inc. is a clinical-stage biopharmaceutical company based in Waltham, Massachusetts, specializing in the discovery and development of advanced antibody-based therapies to combat infectious diseases. The company leverages its proprietary technologies and extensive immunology expertise to address critical unmet medical needs, highlighted by a promising pipeline of innovative therapeutic solutions. By focusing on the development of targeted antibody therapies, Invivyd positions itself at the forefront of biopharmaceutical advancements, aiming to enhance patient outcomes and respond effectively to global health challenges.

LPTX
+368.57%
$2.05
NCPL
+112.47%
$1.40
PAVS
-11.65%
$0.04
NVDA
-0.31%
$184.97
CHR
-6.66%
$0.04
WBD
+3.78%
$28.26
ASST
+3.57%
$1.02
VHAI
-25.00%
$0.00
PLUG
+2.31%
$2.21
ONDS
+2.32%
$9.23
BYND
+10.52%
$1.26
SNTI
-35.56%
$1.54
AXDX
-61.36%
$0.03
AAL
+1.14%
$15.03
TSLA
+1.27%
$445.17
BMNR
+9.40%
$39.21
INTC
+0.49%
$40.50
SOFI
-2.82%
$26.83
CFLT
+0.10%
$29.90
OCG
+291.98%
$10.27
NFLX
-0.08%
$96.71
ADAP
-15.14%
$0.05
GRAB
-0.19%
$5.15
BITF
+3.43%
$3.01
IBIO
+32.93%
$2.22
BAC
-0.66%
$53.54
PFE
-1.70%
$25.33
SOND
-23.45%
$0.12
MARA
+1.65%
$12.25
VOR
+28.22%
$10.72
BMNU
+19.00%
$10.71
T
-1.32%
$24.51
DNN
+0.36%
$2.74
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
BBD
-0.59%
$3.32
ADD
-25.47%
$0.05
WVE
+15.06%
$21.31
AZI
+8.03%
$0.05
KVUE
+1.55%
$17.02
IRBT
+11.35%
$3.53
ABEV
0.00%
$2.47
SRM
+53.27%
$10.30
KITT
+21.42%
$1.06
CRWV
+5.12%
$90.66
WULF
+4.21%
$15.59
BNKK
-34.66%
$0.14
CIFR
+0.41%
$19.56
F
-0.45%
$13.08
CLSK
+6.91%
$14.85
KEY
+3.04%
$19.98
AAPL
-0.25%
$277.18
VZ
-2.80%
$40.14
APLD
+2.05%
$32.77
HPE
+3.81%
$24.77
RGTI
-0.14%
$28.22
CXAI
+21.06%
$0.50
IREN
+1.07%
$46.84
XCUR
+36.77%
$7.29
GOOGL
+1.07%
$317.08
TROX
+25.60%
$4.71
HBAN
+0.29%
$16.99
NIO
-1.37%
$5.03
BTBT
+7.72%
$2.37
MTSR
-0.35%
$70.50
DVLT
+0.64%
$1.57
AMZN
+0.45%
$227.92
RIG
+0.22%
$4.45
AMD
+0.23%
$221.62
BTG
+2.00%
$4.57
ACHR
+0.23%
$8.63
RR
-0.91%
$4.34
SOUN
-2.91%
$12.31
VIVK
-9.95%
$0.07
MSTR
+2.88%
$188.99
XOM
+1.95%
$118.25
AFMD
-34.94%
$0.18
CYPH
+39.65%
$1.62
AVGO
+1.29%
$406.29
SNAP
-1.36%
$7.92
WMT
+1.32%
$115.06
MRVL
-3.36%
$88.90
VALE
-0.07%
$12.80
QBTS
-0.38%
$28.33
RIVN
+0.56%
$17.71
BULL
+5.56%
$10.25
KDP
+0.20%
$29.06
TE
+11.79%
$6.73
CAN
+2.74%
$0.96
GPUS
+7.17%
$0.30
ITUB
+0.39%
$7.60
SLM
-14.95%
$26.23
NVTS
-4.47%
$9.17
GRYP
-10.38%
$1.38
AGNC
-1.42%
$10.34
INHD
+10.48%
$0.15
NCLH
-2.04%
$18.72
HOOD
-0.52%
$135.71
PCG
+0.33%
$14.99
MODV
-25.22%
$0.43
LPTX
+368.57%
$2.05
NCPL
+112.47%
$1.40
PAVS
-11.65%
$0.04
NVDA
-0.31%
$184.97
CHR
-6.66%
$0.04
WBD
+3.78%
$28.26
ASST
+3.57%
$1.02
VHAI
-25.00%
$0.00
PLUG
+2.31%
$2.21
ONDS
+2.32%
$9.23
BYND
+10.52%
$1.26
SNTI
-35.56%
$1.54
AXDX
-61.36%
$0.03
AAL
+1.14%
$15.03
TSLA
+1.27%
$445.17
BMNR
+9.40%
$39.21
INTC
+0.49%
$40.50
SOFI
-2.82%
$26.83
CFLT
+0.10%
$29.90
OCG
+291.98%
$10.27
NFLX
-0.08%
$96.71
ADAP
-15.14%
$0.05
GRAB
-0.19%
$5.15
BITF
+3.43%
$3.01
IBIO
+32.93%
$2.22
BAC
-0.66%
$53.54
PFE
-1.70%
$25.33
SOND
-23.45%
$0.12
MARA
+1.65%
$12.25
VOR
+28.22%
$10.72
BMNU
+19.00%
$10.71
T
-1.32%
$24.51
DNN
+0.36%
$2.74
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
BBD
-0.59%
$3.32
ADD
-25.47%
$0.05
WVE
+15.06%
$21.31
AZI
+8.03%
$0.05
KVUE
+1.55%
$17.02
IRBT
+11.35%
$3.53
ABEV
0.00%
$2.47
SRM
+53.27%
$10.30
KITT
+21.42%
$1.06
CRWV
+5.12%
$90.66
WULF
+4.21%
$15.59
BNKK
-34.66%
$0.14
CIFR
+0.41%
$19.56
F
-0.45%
$13.08
CLSK
+6.91%
$14.85
KEY
+3.04%
$19.98
AAPL
-0.25%
$277.18
VZ
-2.80%
$40.14
APLD
+2.05%
$32.77
HPE
+3.81%
$24.77
RGTI
-0.14%
$28.22
CXAI
+21.06%
$0.50
IREN
+1.07%
$46.84
XCUR
+36.77%
$7.29
GOOGL
+1.07%
$317.08
TROX
+25.60%
$4.71
HBAN
+0.29%
$16.99
NIO
-1.37%
$5.03
BTBT
+7.72%
$2.37
MTSR
-0.35%
$70.50
DVLT
+0.64%
$1.57
AMZN
+0.45%
$227.92
RIG
+0.22%
$4.45
AMD
+0.23%
$221.62
BTG
+2.00%
$4.57
ACHR
+0.23%
$8.63
RR
-0.91%
$4.34
SOUN
-2.91%
$12.31
VIVK
-9.95%
$0.07
MSTR
+2.88%
$188.99
XOM
+1.95%
$118.25
AFMD
-34.94%
$0.18
CYPH
+39.65%
$1.62
AVGO
+1.29%
$406.29
SNAP
-1.36%
$7.92
WMT
+1.32%
$115.06
MRVL
-3.36%
$88.90
VALE
-0.07%
$12.80
QBTS
-0.38%
$28.33
RIVN
+0.56%
$17.71
BULL
+5.56%
$10.25
KDP
+0.20%
$29.06
TE
+11.79%
$6.73
CAN
+2.74%
$0.96
GPUS
+7.17%
$0.30
ITUB
+0.39%
$7.60
SLM
-14.95%
$26.23
NVTS
-4.47%
$9.17
GRYP
-10.38%
$1.38
AGNC
-1.42%
$10.34
INHD
+10.48%
$0.15
NCLH
-2.04%
$18.72
HOOD
-0.52%
$135.71
PCG
+0.33%
$14.99
MODV
-25.22%
$0.43

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.